Metformin's Effect on Biological Ageing in Prediabetes: New 2026 Indian Study Written By Dr. Nandita Mohan16 Oct 2026 11:28 AM ISTMetformin increased leukocyte telomere length, telomerase activity and SIRT1 expression in Indian adults with prediabetes, suggesting potential...
Resting Heart Rate and CV Outcomes in Hypertension: Revisiting the Accessible Clinical Marker Written By Dr Ravindra Sangolkar15 Oct 2026 12:00 PM IST Hypertension remains a major contributor to cardiovascular morbidity and mortality; however, cardiovascular risk extends beyond blood pressure...
Clinical Perspectives of Fexofenadine and Pseudoephdrine in Indian Allergic Rhinitis Patients - Dr. Sanjay Sachdeva Written By Dr. Sanjay Sachdeva15 Oct 2026 11:27 AM ISTAllergic rhinitis is a common inflammatory condition of the upper airway associated with significant morbidity and reduced quality of life. It can be...
The Case of the Ill-Fated Abandoned Neonate - Dr Pratibha Kane Written By Dr Pratibha Kane12 Oct 2026 2:30 PM ISTThere is a recent surge of court rulings to terminate pregnancy in rape victims beyond 20 weeks to preserve their bodily autonomy and dignity. The...
Dapagliflozin-Metformin in the Diabetes Care Continuum: When to Consider?- Dr Praveen G Written By Dr Praveen Gangadhara12 Oct 2026 10:49 AM ISTCombination Therapy-Pillars in Diabetes Care Continuum Type 2 diabetes mellitus (T2DM) represents a significant and escalating health challenge,...
Lp(a) and the EAS Risk Calculator: Bringing Hidden Cardiovascular Risk into Clinical View-Dr Suraj Patil Written By Dr. Suraj Patil10 Oct 2026 11:40 AM ISTBackground: Lp(a) as an Independent, Genetically-Determined CV Risk Factor Cardiovascular risk assessment has conventionally relied on established...
Clinical Insights for Allergic Rhinitis Management with Fexofenadine and Pseudoephedrine Combination - Dr. Dwaipayan Mukherjee Written By Dr. Dwaipayan Mukherjee8 Oct 2026 11:45 AM ISTAllergic rhinitis (AR) is a common atopic condition characterised by symptoms such as nasal congestion, clear rhinorrhoea, sneezing, postnasal drip,...
Managing Hypertension in MI Patients: Key Updates for Clinicians & Place of Telmisartan and Metoprolol Written By Dr Anil D. Katdare7 Oct 2026 10:30 AM IST Hypertension remains a major determinant of adverse outcomes after myocardial infarction (MI), contributing to recurrent ischemia, adverse left...
Dapagliflozin - Five Years since CKD Approval: Revisiting 5 Milestones in CKD Care Written By Dr. Shyam Sundar C M1 Oct 2026 11:00 AM ISTFive years ago, the approval of dapagliflozin for chronic kidney disease (CKD) by the US FDA marked a pivotal shift in nephrology practice. 1 What...
Comparing Metoprolol vs. Bisoprolol in Acute Myocardial Infarction (AMI): ESC 2026 Update Written By Prem Aggarwal25 Sept 2026 11:51 AM ISTBisoprolol was associated with higher all-cause and cardiovascular mortality compared with metoprolol in patients with Acute Myocardial Infarction,...
Blood Test Accurately Detects Alzheimer's Amyloid Pathology in Symptomatic Adults: Latest 2026 Study Findings Written By Medical Dialogues Team19 Sept 2026 10:00 AM IST Blood-based biomarker test combining plasma phosphorylated tau 217 (p-tau217) and amyloid beta 1-42 can accurately identify amyloid pathology in...
Ten Years to Dapagliflozin Metformin FDC Approval in India - 10 Key Points to Revisit Written By Dr Tata Sameer Nandan12 Sept 2026 10:15 AM ISTType 2 diabetes mellitus (T2DM) affects an estimated 589 million adults globally, with India accounting for nearly 89.8 million cases, making early...
